Mckenzie-Willamette Regional Medical Center Associates LLC
Mckenzie-Willamette Regional Medical Center Associates LLC was paid $44.67M by Medicaid between Jan 2018 and Dec 2024, across 96 billing codes. Its largest line is 99284, emergency room visit (serious) — 40% of everything it billed.
SPRINGFIELD, OR 97477
Next to other Ambulatory Surgical Clinic/Center providers in Oregon
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 88,398 | $6.52M | |
| 2019 | 99,676 | $6.02M | |
| 2020 | 101,451 | $5.61M | |
| 2021 | 96,990 | $6.12M | |
| 2022 | 90,376 | $5.34M | |
| 2023 | 118,045 | $7.23M | |
| 2024incomplete | 110,498 | $7.84M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 40% | 69,681 | 61,424 | $18.07M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 60,839 | 55,522 | $10.90M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.1% | 13,479 | 11,281 | $4.09M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7.4% | 30,991 | 26,770 | $3.31M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 5.5% | 17,429 | 6,534 | $2.47M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.2% | 32,855 | 16,723 | $965K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 9,126 | 8,478 | $952K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.9% | 22,562 | 19,407 | $834K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 17,890 | 15,498 | $492K |
| 71045 | Radiologic examination, chest; single view | <1% | 10,555 | 8,951 | $429K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 7,676 | 7,075 | $427K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,866 | 7,872 | $424K |
84 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,382 | $379K |
| 97597 | <1% | 3,970 | $227K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 4,210 | $223K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,310 | $200K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 838 | $90K |
| S9480 | Intensive outpatient psychiatric services, per diem | <1% | 76 | $72K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 168 | $28K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,978 | $22K |
| 87631 | <1% | 4,320 | $19K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 138 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 340 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 14,163 | $4K |
| 10060 | <1% | 13 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 220 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 26,901 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 64 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 64 | $1K |
| 86900 | <1% | 13 | $859.63 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 16 | $723.88 |
| 80053 | Comprehensive metabolic panel | <1% | 60,455 | $677.95 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 65,101 | $522.35 |
| 36415 | Collection of venous blood by venipuncture | <1% | 54,983 | $421.49 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,514 | $315.16 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 175 | $280.63 |
| 81025 | <1% | 9,626 | $217.67 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,187 | $209.42 |
| 84484 | <1% | 19,408 | $160.18 | |
| A9270 | Non-covered item or service | <1% | 4,207 | $144.37 |
| 81001 | <1% | 34,837 | $91.94 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 996 | $86.22 |
| 83690 | <1% | 15,894 | $82.70 | |
| 73562 | <1% | 50 | $71.51 | |
| 87077 | <1% | 1,654 | $63.41 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 516 | $55.93 |
| 87186 | <1% | 1,079 | $54.04 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 155 | $31.82 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 303 | $18.47 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,259 | $17.63 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,468 | $15.61 |
| 83735 | <1% | 1,509 | $15.61 | |
| 84702 | <1% | 160 | $13.30 | |
| 87070 | <1% | 1,249 | $11.82 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,320 | $7.44 |
| 87205 | <1% | 1,198 | $5.86 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 14,944 | $4.27 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 11,820 | $0.03 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 6,794 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 78 | $0.00 |
| 84145 | 0% | 248 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 11,801 | $0.00 |
| 73030 | 0% | 16 | $0.00 | |
| 87075 | 0% | 203 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 148 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 15 | $0.00 |
| 85610 | 0% | 69 | $0.00 | |
| 87210 | 0% | 12 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 13 | $0.00 |
| 73630 | 0% | 14 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 4,266 | $0.00 |
| 87430 | 0% | 138 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 1,265 | $0.00 |
| 83605 | 0% | 158 | $0.00 | |
| 83880 | 0% | 1,070 | $0.00 | |
| 96376 | 0% | 346 | $0.00 | |
| 94761 | 0% | 1,892 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 164 | $0.00 |
| 82962 | 0% | 108 | $0.00 | |
| 84703 | 0% | 231 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 224 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 63 | $0.00 |
| 11045 | 0% | 285 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 39 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 66 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 251 | $0.00 |
| 87040 | 0% | 71 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 15 | $0.00 |
| 86850 | 0% | 13 | $0.00 | |
| G0378 | Hospital observation service, per hour | 0% | 58 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 32 | $0.00 |
| 85730 | 0% | 13 | $0.00 | |
| 87081 | 0% | 12 | $0.00 | |
| 86901 | 0% | 13 | $0.00 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 14 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Deming Hospital Corporation | Deming, NM | $11.41M |
| Three Rivers Medical Clinics INC | Louisa, KY | $7.06M |
| Ambulance Services of Forrest City LLC | Forrest City, AR | $3.51M |
| Ambulance Services of Tooele, LLC | Tooele, UT | $3.42M |
| Paintsville Hma Physician Management, LLC | Paintsville, KY | $2.41M |
| Deming Clinic Corporation | Deming, NM | $2.06M |
| Fort Payne Clinic Corp. | Fort Payne, AL | $2.00M |
| San Miguel Clinic Corp | Las Vegas, NM | $1.76M |
| Fort Payne RHC Corp | Fort Payne, AL | $1.76M |
| Jackson Hospital Corporation | Beattyville, KY | $1.68M |
| Tooele Clinic Corp | Tooele, UT | $1.29M |
| Williamston Clinic Corp | Williamston, NC | $1.26M |
| Mckenzie Physician Services LLC | Brentwood, TN | $1.24M |
| Anna Hospital Corporation | Anna, IL | $1.17M |
| Big Bend Hospital Corporation | Alpine, TX | $952K |
| Kentucky River Physician Corporation | Jackson, KY | $948K |
| Fort Payne HBP LLC | Fort Payne, AL | $731K |
| Forrest City Clinic Company LLC | Forrest City, AR | $702K |
| Mesquite Clinic Management Company LLC | Logandale, NV | $597K |
| Mesquite Clinic Management Company LLC | Mesquite, NV | $556K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.